Tom Colley

Naltrexone in the Treatment of Ketamine Use Disorders: A Case Report and Literature Review.

Journal of Addiction Medicine October 2, 2025 Rishi Verma, Tom Colley, Claire Waldock et al. 1 citation

Nonprescribed use of ketamine has increased worldwide due to its hallucinogenic and psychedelic effects. Ketamine use disorders (KUDs) are marked by intense cravings and tolerance, which often trigger relapses and worsen recovery outcomes, defined as sustained ketamine abstinence with reduced cravings, resolved withdrawal symptoms, and improved psychosocial functioning. Currently, there are no...